Ahomocysteinemia in molybdenum cofactor deficiency

Neurology
1998.0

Abstract

We report an infant with molybdenum cofactor deficiency (MCD) and a unique clinical presentation of hemiplegia, hypotonia, dystonia, and bilateral basal ganglia changes. Biochemistry revealed absent serum homocysteine, low concentrations of plasma cystine, high levels of urinary S-sulfocysteine and sulfite, and high levels of oxypurines in serum and urine. The depletion of cysteine and cystine through reaction with sulfite suggests that other thiols and thiol-dependent proteins may be similarly depleted. Ahomocysteinemia may be a clue to the mechanism of cytotoxicity in MCD.

Knowledge Graph

Similar Paper

Ahomocysteinemia in molybdenum cofactor deficiency
Neurology 1998.0
Reduced glutathione, γ‐glutamylcysteine, cysteine and γ‐glutamylglutamine in γ‐glutamyltransferase deficiency
Journal of Inherited Metabolic Disease 1999.0
Discovery and Characterization of a Second Mammalian Thiol Dioxygenase, Cysteamine Dioxygenase
Journal of Biological Chemistry 2007.0
Reference data for cerebrospinal fluid and the utility of amino acid measurement for the diagnosis of inborn errors of metabolism
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2006.0
Acute metabolic crisis with extreme deficiency of glutathione in combination with decreased CSF levels of leukotriene C<sub>4</sub> in a patient with glutathione synthetase deficiency
Journal of Inherited Metabolic Disease 2004.0
One‐methyl group metabolism in non‐ketotic hyperglycinaemia: Mildly elevated cerebrospinal fluid homocysteine levels
Journal of Inherited Metabolic Disease 1998.0
Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency
Molecular Genetics and Metabolism 2007.0
Infantile Refsum's disease: Biochemical findings suggesting multiple peroxisomal dysfunction
Journal of Inherited Metabolic Disease 1986.0
New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?
Biochemical Journal 2004.0
Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis
Bioorganic &amp; Medicinal Chemistry Letters 2011.0